Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(2):176–180. doi: 10.1155/S1064744997000264

Cell Damage at the Origin of Antiphospholipid Antibodies and Their Pathogenic Potential in Recurrent Pregnancy Loss

Véronique Piroux 1, Valérie Eschwège 2, Jean-Marie Freyssinet 1,2,✉
PMCID: PMC2364567  PMID: 18476171

Abstract

Antiphospholipid antibodies (APA) are associated with thrombosis, thrombocytopenia and fetal loss but they occur in a variety of diseases. Despite many efforts, a correlation between the specificity of particular subgroups of APA and particular clinical situations remains to be established. The antigens at the origin of APA remain to be identified. We discuss here the possible links between cell apoptosis or necrosis, leading to plasma membrane alterations, and the occurrence of APA in response to sustained stimulation. The pathogenic potential of APA is also considered with respect to recurrent pregnancy loss.

Full Text

The Full Text of this article is available as a PDF (403.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams C., Shattil S. J. Immunological detection of activated platelets in clinical disorders. Thromb Haemost. 1991 May 6;65(5):467–473. [PubMed] [Google Scholar]
  2. Aloia R. C., Tian H., Jensen F. C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5181–5185. doi: 10.1073/pnas.90.11.5181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Antonopoulou S., Demopoulos C. A., Iatrou C. Blood cardiolipin in haemodialysis patients. Its implication in the biological action of platelet-activating factor. Int J Biochem Cell Biol. 1996 Jan;28(1):43–51. doi: 10.1016/1357-2725(95)00116-6. [DOI] [PubMed] [Google Scholar]
  4. Arvieux J., Darnige L., Hachulla E., Roussel B., Bensa J. C., Colomb M. G. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb Haemost. 1996 May;75(5):725–730. [PubMed] [Google Scholar]
  5. Aupeix K., Hugel B., Martin T., Bischoff P., Lill H., Pasquali J. L., Freyssinet J. M. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest. 1997 Apr 1;99(7):1546–1554. doi: 10.1172/JCI119317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bennett M. R., Gibson D. F., Schwartz S. M., Tait J. F. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res. 1995 Dec;77(6):1136–1142. doi: 10.1161/01.res.77.6.1136. [DOI] [PubMed] [Google Scholar]
  7. Casciola-Rosen L., Rosen A., Petri M., Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1624–1629. doi: 10.1073/pnas.93.4.1624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chedid A., Chadalawada K. R., Morgan T. R., Moritz T. E., Mendenhall C. L., Hammond J. B., Emblad P. W., Cifuentes D. C., Kwak J. W., Gilman-Sachs A. Phospholipid antibodies in alcoholic liver disease. Hepatology. 1994 Dec;20(6):1465–1471. doi: 10.1002/hep.1840200614. [DOI] [PubMed] [Google Scholar]
  9. Chonn A., Semple S. C., Cullis P. R. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem. 1995 Oct 27;270(43):25845–25849. doi: 10.1074/jbc.270.43.25845. [DOI] [PubMed] [Google Scholar]
  10. Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992 Apr 1;148(7):2207–2216. [PubMed] [Google Scholar]
  11. Galli M., Bevers E. M., Comfurius P., Barbui T., Zwaal R. F. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol. 1993 Mar;83(3):466–472. doi: 10.1111/j.1365-2141.1993.tb04672.x. [DOI] [PubMed] [Google Scholar]
  12. Galli M., Finazzi G., Barbui T. Antiphospholipid antibodies: predictive value of laboratory tests. Thromb Haemost. 1997 Jul;78(1):75–78. [PubMed] [Google Scholar]
  13. Galli M., Grassi A., Barbui T. Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Haemost. 1996 Mar;75(3):427–431. [PubMed] [Google Scholar]
  14. George J. N., Pickett E. B., Saucerman S., McEver R. P., Kunicki T. J., Kieffer N., Newman P. J. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest. 1986 Aug;78(2):340–348. doi: 10.1172/JCI112582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gotoh M., Matsuda J. Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of an anti-cardiolipin antibody. Am J Hematol. 1995 Nov;50(3):220–222. doi: 10.1002/ajh.2830500312. [DOI] [PubMed] [Google Scholar]
  16. Hamilton K. K., Hattori R., Esmon C. T., Sims P. J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem. 1990 Mar 5;265(7):3809–3814. [PubMed] [Google Scholar]
  17. Holme P. A., Solum N. O., Brosstad F., Røger M., Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost. 1994 Nov;72(5):666–671. [PubMed] [Google Scholar]
  18. Jy W., Horstman L. L., Arce M., Ahn Y. S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992 Apr;119(4):334–345. [PubMed] [Google Scholar]
  19. Martin S. J., Reutelingsperger C. P., McGahon A. J., Rader J. A., van Schie R. C., LaFace D. M., Green D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995 Nov 1;182(5):1545–1556. doi: 10.1084/jem.182.5.1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nomura S., Yanabu M., Fukuroi T., Kido H., Kawakatsu T., Yamaguchi K., Suzuki M., Kokawa T., Yasunaga K. Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura. Ann Hematol. 1992 Jul;65(1):46–49. doi: 10.1007/BF01715126. [DOI] [PubMed] [Google Scholar]
  21. Nomura S., Yanabu M., Miyake T., Miyazaki Y., Kido H., Kagawa H., Fukuhara S., Komiyama Y., Matsuura E., Koike T. Relationship of microparticles with beta 2-glycoprotein I and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura. Ann Hematol. 1995 Jan;70(1):25–30. doi: 10.1007/BF01715378. [DOI] [PubMed] [Google Scholar]
  22. Prieto J., Yuste J. R., Beloqui O., Civeira M. P., Riezu J. I., Aguirre B., Sangro B. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996 Feb;23(2):199–204. doi: 10.1002/hep.510230201. [DOI] [PubMed] [Google Scholar]
  23. Rand J. H., Wu X. X., Andree H. A., Lockwood C. J., Guller S., Scher J., Harpel P. C. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. N Engl J Med. 1997 Jul 17;337(3):154–160. doi: 10.1056/NEJM199707173370303. [DOI] [PubMed] [Google Scholar]
  24. Santoro S. A. Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms. Blood. 1994 May 1;83(9):2389–2391. [PubMed] [Google Scholar]
  25. Satta N., Toti F., Feugeas O., Bohbot A., Dachary-Prigent J., Eschwège V., Hedman H., Freyssinet J. M. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994 Oct 1;153(7):3245–3255. [PubMed] [Google Scholar]
  26. Stasi R., Stipa E., Masi M., Oliva F., Sciarra A., Perrotti A., Olivieri M., Zaccari G., Gandolfo G. M., Galli M. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood. 1994 Dec 15;84(12):4203–4208. [PubMed] [Google Scholar]
  27. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 1995 Mar 10;267(5203):1456–1462. doi: 10.1126/science.7878464. [DOI] [PubMed] [Google Scholar]
  28. Triplett D. A. Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemost. 1995 Jul;74(1):329–337. [PubMed] [Google Scholar]
  29. Verhoven B., Schlegel R. A., Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med. 1995 Nov 1;182(5):1597–1601. doi: 10.1084/jem.182.5.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Violi F., Ferro D., Basili S., Artini M., Valesini G., Levrero M., Cordova C. Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis. J Investig Med. 1995 Dec;43(6):550–554. [PubMed] [Google Scholar]
  31. Warkentin T. E., Hayward C. P., Boshkov L. K., Santos A. V., Sheppard J. A., Bode A. P., Kelton J. G. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994 Dec 1;84(11):3691–3699. [PubMed] [Google Scholar]
  32. Zwaal R. F., Schroit A. J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997 Feb 15;89(4):1121–1132. [PubMed] [Google Scholar]
  33. al-Saeed A., Makris M., Malia R. G., Preston F. E., Greaves M. The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Haematol. 1994 Dec;88(4):845–848. doi: 10.1111/j.1365-2141.1994.tb05126.x. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES